| Home | E-Submission | Sitemap | Editorial Office |  
top_img
Clinical and Molecular Hepatology Search > Browse Articles > Search



Reversible splenial lesion on the corpus callosum in nonfulminant hepatitis A presenting as encephalopathy
Soon Young Ko, Byung Kook Kim, Dong Wook Kim, Jeong Han Kim, Won Hyeok Choe, Hee Yeon Seo, So Young Kwon
Clin Mol Hepatol.2014;20(4):398-401.   Published online December 24, 2014     
DOI: https://doi.org/10.3350/cmh.2014.20.4.398
                                 Cited By 6
A case of focal nodular hyperplasia with growth progression during pregnancy
Min Ji Kim, Sang Young Han, Yang Hyun Baek, Sung Wook Lee, Hee Jin Kwon
Clin Mol Hepatol.2014;20(4):392-397.   Published online December 24, 2014     
DOI: https://doi.org/10.3350/cmh.2014.20.4.392
                                 Cited By 1
Safety, efficacy, and response predictors of anticoagulation for the treatment of nonmalignant portal-vein thrombosis in patients with cirrhosis: a propensity score matching analysis
Jung Wha Chung, Gi Hyun Kim, Jong Ho Lee, Kyeong Sam Ok, Eun Sun Jang, Sook-Hyang Jeong, Jin-Wook Kim
Clin Mol Hepatol.2014;20(4):384-391.   Published online December 24, 2014     
DOI: https://doi.org/10.3350/cmh.2014.20.4.384
                                 Cited By 24
Effects of candesartan and propranolol combination therapy versus propranolol monotherapy in reducing portal hypertension
Jae Hyun Kim, Jung Min Kim, Youn Zoo Cho, Ji Hoon Na, Hyun Sik Kim, Hyoun A Kim, Hye Won Kang, Soon Koo Baik, Sang Ok Kwon, Seung Hwan Cha, Young Ju Kim, Moon Young Kim
Clin Mol Hepatol.2014;20(4):376-383.   Published online December 24, 2014     
DOI: https://doi.org/10.3350/cmh.2014.20.4.376
                                 Cited By 14
Predictors of spontaneous viral clearance and outcomes of acute hepatitis C infection
Yoo-Kyung Cho, Young Nam Kim, Byung-Cheol Song
Clin Mol Hepatol.2014;20(4):368-375.   Published online December 24, 2014     
DOI: https://doi.org/10.3350/cmh.2014.20.4.368
                                 Cited By 5
Geographic differences in the epidemiological features of HCV infection in Korea
Kyung-Ah Kim, Sook-Hyang Jeong, Eun Sun Jang, Young Seok Kim, Youn Jae Lee, Eun Uk Jung, In Hee Kim, Sung Bum Cho, Mee-Kyung Kee, Chun Kang
Clin Mol Hepatol.2014;20(4):361-367.   Published online December 24, 2014     
DOI: https://doi.org/10.3350/cmh.2014.20.4.361
                                 Cited By 7
Is it necessary to delay antiviral therapy for 3-6 months to anticipate HBeAg seroconversion in patients with HBeAg-positive chronic hepatitis B in endemic areas of HBV genotype C? [corrected-article]
Byung-Cheol Song, Yoo-Kyung Cho, Hyeyoung Jwa, Eun Kwang Choi, Heung Up Kim, Hyun Joo Song, Soo-Young Na, Sun-Jin Boo, Seung Uk Jeong
Clin Mol Hepatol.2014;20(4):355-360.   Published online December 24, 2014     
DOI: https://doi.org/10.3350/cmh.2014.20.4.355
                                 Cited By 3
Serum transferrin as a liver fibrosis biomarker in patients with chronic hepatitis B
Hyo Jung Cho, Soon Sun Kim, Seun Joo Ahn, Joo Han Park, Dong Joon Kim, Young Bae Kim, Sung Won Cho, Jae Youn Cheong
Clin Mol Hepatol.2014;20(4):347-354.   Published online December 24, 2014     
DOI: https://doi.org/10.3350/cmh.2014.20.4.347
                                 Cited By 8
Management of viral hepatitis in liver transplant recipients
Soung Won Jeong, YoungRok Choi, Jin-Wook Kim
Clin Mol Hepatol.2014;20(4):338-344.   Published online December 24, 2014     
DOI: https://doi.org/10.3350/cmh.2014.20.4.338
                                 Cited By 3
Cost-of-illness studies: concepts, scopes, and methods
Changik Jo
Clin Mol Hepatol.2014;20(4):327-337.   Published online December 24, 2014     
DOI: https://doi.org/10.3350/cmh.2014.20.4.327
                                 Cited By 79
Chemotherapy induced liver abnormalities: an imaging perspective
Ankush Sharma, Roozbeh Houshyar, Priya Bhosale, Joon-Il Choi, Rajesh Gulati, Chandana Lall
Clin Mol Hepatol.2014;20(3):317-326.   Published online September 25, 2014     
DOI: https://doi.org/10.3350/cmh.2014.20.3.317
                                 Cited By 12
Sarcomatoid hepatocellular carcinoma with mixed osteoclast-like giant cells and chondroid differentiation
Kyoung-Bun Lee
Clin Mol Hepatol.2014;20(3):313-316.   Published online September 26, 2014     
DOI: https://doi.org/10.3350/cmh.2014.20.3.313
                                 Cited By 7
A synchronous hepatocellular carcinoma and renal cell carcinoma treated with radio-frequency ablation
Yoon Serk Lee, Jeong Han Kim, Hyeon Young Yoon, Won Hyeok Choe, So Young Kwon, Chang Hong Lee
Clin Mol Hepatol.2014;20(3):306-309.   Published online September 25, 2014     
DOI: https://doi.org/10.3350/cmh.2014.20.3.306
                                 Cited By 1
Gastrectomy for the treatment of refractory gastric ulceration after radioembolization with 90Y microspheres
Sun Young Yim, Jin Dong Kim, Jin Yong Jung, Chang Ha Kim, Yeon Seok Seo, Hyung Joon Yim, Soon Ho Um, Ho Sang Ryu, Yun Hwan Kim, Chong Suk Kim, Eun Shin
Clin Mol Hepatol.2014;20(3):300-305.   Published online September 25, 2014     
DOI: https://doi.org/10.3350/cmh.2014.20.3.300
                                 Cited By 6
Safety of reduced dose of mycophenolate mofetil combined with tacrolimus in living-donor liver transplantation
Hyeyoung Kim, Nam-Joon Yi, Juyeun Lee, Joohyun Kim, Mi-Ra Moon, Jaehong Jeong, Jeong-Moo Lee, Tae Suk You, Suk-Won Suh, Min-Su Park, YoungRok Choi, Geun Hong, Hae Won Lee, Kwang-Woong Lee, Kyung-Suk Suh
Clin Mol Hepatol.2014;20(3):291-299.   Published online September 25, 2014     
DOI: https://doi.org/10.3350/cmh.2014.20.3.291
                                 Cited By 5
The comparison of esophageal variceal ligation plus propranolol versus propranolol alone for the primary prophylaxis of esophageal variceal bleeding
Dongmo Je, Yong-Han Paik, Geum-Youn Gwak, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Byung Chul Yoo
Clin Mol Hepatol.2014;20(3):283-290.   Published online September 25, 2014     
DOI: https://doi.org/10.3350/cmh.2014.20.3.283
                                 Cited By 5
Hepatitis B surface antigen levels at 6 months after treatment can predict the efficacy of lamivudine-adefovir combination therapy in patients with lamivudine-resistant chronic hepatitis B
Jeong Han Kim, Hee Won Moon, Soon Young Ko, Won Hyeok Choe, So Young Kwon
Clin Mol Hepatol.2014;20(3):274-282.   Published online September 25, 2014     
DOI: https://doi.org/10.3350/cmh.2014.20.3.274
                                 Cited By 1
Long-term outcomes of two rescue therapies in lamivudine-refractory patients with chronic hepatitis B: combined lamivudine and adefovir, and 1-mg entecavir
EunYoung Ze, Eun Kyung Baek, Jong Jin Lee, Han Wook Chung, Dae Geon Ahn, Hwan Jun Cho, Jae Cheol Kwon, Hyung Joon Kim, HyunWoong Lee
Clin Mol Hepatol.2014;20(3):267-273.   Published online September 25, 2014     
DOI: https://doi.org/10.3350/cmh.2014.20.3.267
                                 Cited By 5
Tenofovir disoproxil fumarate monotherapy for nucleos(t)ide-naïve chronic hepatitis B patients in Korea: data from the clinical practice setting in a single-center cohort
Sung Soo Ahn, Young Eun Chon, Beom Kyung Kim, Seung Up Kim, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Jun Yong Park
Clin Mol Hepatol.2014;20(3):261-266.   Published online September 25, 2014     
DOI: https://doi.org/10.3350/cmh.2014.20.3.261
                                 Cited By 7
Spontaneous HBsAg loss in Korean patients: relevance of viral genotypes, S gene mutations, and covalently closed circular DNA copy numbers
Kyun-Hwan Kim, Hye-Young Chang, Jun Yong Park, Eun-Sook Park, Yong Kwang Park, Kwang-Hyub Han, Sang Hoon Ahn
Clin Mol Hepatol.2014;20(3):251-260.   Published online September 25, 2014     
DOI: https://doi.org/10.3350/cmh.2014.20.3.251
                                 Cited By 6
Occult hepatitis B virus infection: clearance or disguise?
Jin-Wook Kim
Clin Mol Hepatol.2014;20(3):249-250.   Published online September 25, 2014     
DOI: https://doi.org/10.3350/cmh.2014.20.3.249
                              
Factors affecting drug-induced liver injury: antithyroid drugs as instances
Reza Heidari, Hossein Niknahad, Akram Jamshidzadeh, Narges Abdoli
Clin Mol Hepatol.2014;20(3):237-248.   Published online September 25, 2014     
DOI: https://doi.org/10.3350/cmh.2014.20.3.237
                                 Cited By 26
Prediction of fibrosis progression in chronic viral hepatitis
Grace Lai-Hung Wong
Clin Mol Hepatol.2014;20(3):228-236.   Published online September 25, 2014     
DOI: https://doi.org/10.3350/cmh.2014.20.3.228
                                 Cited By 21
Risk stratification of HBV infection in Asia-Pacific region
Jia-Horng Kao
Clin Mol Hepatol.2014;20(3):223-227.   Published online September 25, 2014     
DOI: https://doi.org/10.3350/cmh.2014.20.3.223
                                 Cited By 11
Magnetic resonance imaging following treatment of advanced hepatocellular carcinoma with sorafenib
Joon-Il Choi, David K Imagawa, Priya Bhosale, Puneet Bhargava, Temel Tirkes, Tara E Seery, Chandana Lall
Clin Mol Hepatol.2014;20(2):218-222.   Published online June 30, 2014     
DOI: https://doi.org/10.3350/cmh.2014.20.2.218
                                 Cited By 3
Intrahepatic cholangiocarcinoma with predominant ductal plate malformation pattern
Ji-Young Choe, Haeryoung Kim
Clin Mol Hepatol.2014;20(2):214-217.   Published online June 30, 2014     
DOI: https://doi.org/10.3350/cmh.2014.20.2.214
                                 Cited By 3
A case of obstructive jaundice caused by tuberculous lymphadenitis: A literature review
Su Jung Baik, Kwon Yoo, Tae Hun Kim, Il Hwan Moon, Min-Sun Cho
Clin Mol Hepatol.2014;20(2):208-213.   Published online June 30, 2014     
DOI: https://doi.org/10.3350/cmh.2014.20.2.208
                                 Cited By 5
Pure red-cell aplasia and autoimmune hemolytic anemia in a patient with acute hepatitis A
Hyo Jeong Chang, Dong Hyun Sinn, Sung Gyun Cho, Tae Hoon Oh, Tae Joo Jeon, Won Chang Shin, Won Choong Choi
Clin Mol Hepatol.2014;20(2):204-207.   Published online June 30, 2014     
DOI: https://doi.org/10.3350/cmh.2014.20.2.204
                                 Cited By 2
Impact of immunosuppressant therapy on early recurrence of hepatocellular carcinoma after liver transplantation
Ju-Yeun Lee, Yul Hee Kim, Nam-Joon Yi, Hyang Sook Kim, Hye Suk Lee, Byung Koo Lee, Hyeyoung Kim, Young Rok Choi, Geun Hong, Kwang-Woong Lee, Kyung-Suk Suh
Clin Mol Hepatol.2014;20(2):192-203.   Published online June 30, 2014     
DOI: https://doi.org/10.3350/cmh.2014.20.2.192
                                 Cited By 11
Prevalence of renal dysfunction in patients with cirrhosis according to ADQI-IAC working party proposal
Yun Jung Choi, Jeong Han Kim, Ja Kyung Koo, Cho I Lee, Ji Young Lee, Jae Hoon Yang, Soon Young Ko, Won Hyeok Choe, So Young Kwon, Chang Hong Lee
Clin Mol Hepatol.2014;20(2):185-191.   Published online June 30, 2014     
DOI: https://doi.org/10.3350/cmh.2014.20.2.185
                                 Cited By 9
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | Next
E-Submission
Email Alert
Author's Index
EndNote Style file download
The Korean Association for the Study of the Liver
The Liver Week 2019
SCImago Journal & Country Rank
PubMed Central
PubMed
Scopus
KoreaMed
KoMCI
ScienceCentral
DOAJ
GoogleScholar
Similarity Check
Crossref Cited-by Linking
CrossMark
Funder Registry
ORCID
MeSH on Demand
COPE
Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © The Korean Association for the Study of the Liver. All rights reserved.         
COUNTER
TODAY : 157
TOTAL : 227791